Effects of switching from placebo to peginterferon beta-1A in the advance study in patients with relapsing multiple sclerosis

Authors
Category Primary study
JournalJOURNAL OF THE NEUROLOGICAL SCIENCES
Year 2015
This article has no abstract
Epistemonikos ID: 6b6e4a258709fdd57d9a714c0cfd0c3ae0acdb72
First added on: Mar 31, 2022